188 related articles for article (PubMed ID: 31327283)
1. Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost-effectiveness analysis.
Avram CM; Shaffer BL; Sparks TN; Allen AJ; Caughey AB
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1732-1740. PubMed ID: 31327283
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of ultrasound before non-invasive prenatal screening for fetal aneuploidy.
Battarbee AN; Vora NL; Hardisty EE; Stamilio DM
Ultrasound Obstet Gynecol; 2023 Mar; 61(3):325-332. PubMed ID: 36273429
[TBL] [Abstract][Full Text] [Related]
3. Isolated echogenic intracardiac foci and the role of cell-free fetal DNA: A cost-effectiveness analysis.
Hacker FM; Hersh AR; Shaffer BL; Caughey AB
Prenat Diagn; 2020 Dec; 40(12):1517-1524. PubMed ID: 32716062
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
Shaffer BL; Norton ME
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
[TBL] [Abstract][Full Text] [Related]
5. Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies.
Zhang J; Wu Y; Chen S; Luo Q; Xi H; Li J; Qin X; Peng Y; Ma N; Yang B; Qiu X; Lu W; Chen Y; Jiang Y; Chen P; Liu Y; Zhang C; Zhang Z; Xiong Y; Shen J; Liang H; Ren Y; Ying C; Dong M; Li X; Xu C; Wang H; Zhang D; Xu C; Huang H
Nat Med; 2024 Feb; 30(2):470-479. PubMed ID: 38253798
[TBL] [Abstract][Full Text] [Related]
6. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
7. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
[TBL] [Abstract][Full Text] [Related]
11. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
12. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
13. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
[TBL] [Abstract][Full Text] [Related]
14. Early detection of active Human CytomegaloVirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing.
Faas BHW; Astuti G; Melchers WJG; Reuss A; Gilissen C; Macville MVE; Ghesquiere SAI; Houben LMH; Srebniak MI; Geeven G; Rahamat-Langendoen JC; Sistermans EA; Linthorst J
EBioMedicine; 2024 Feb; 100():104983. PubMed ID: 38365322
[TBL] [Abstract][Full Text] [Related]
15. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.
Nshimyumukiza L; Beaumont JA; Duplantie J; Langlois S; Little J; Audibert F; McCabe C; Gekas J; Giguère Y; Gagné C; Reinharz D; Rousseau F
J Obstet Gynaecol Can; 2018 Jan; 40(1):48-60. PubMed ID: 28784564
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis.
Chau MHK; Cao Y; Kwok YKY; Chan S; Chan YM; Wang H; Yang Z; Wong HK; Leung TY; Choy KW
Am J Obstet Gynecol; 2019 Nov; 221(5):493.e1-493.e11. PubMed ID: 31207233
[TBL] [Abstract][Full Text] [Related]
18. [What are the real purpose and scope of screening for aneuploidy?].
Quibel T; Rozenberg P
Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
[TBL] [Abstract][Full Text] [Related]
19. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
Bevilacqua E; Jani JC; Chaoui R; Suk EA; Palma-Dias R; Ko TM; Warsof S; Stokowski R; Jones KJ; Grati FR; Schmid M
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):597-602. PubMed ID: 34090308
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.
Dar P; Jacobsson B; Clifton R; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Strong N; Haeri S; Silver R; Vohra N; Hyett J; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Daly S; Hallingström M; MacPherson C; Kao C; Hakonarson H; Norton ME
Am J Obstet Gynecol; 2022 Jul; 227(1):79.e1-79.e11. PubMed ID: 35033576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
